Literature DB >> 6701538

Biochemistry of human plasminogen.

F J Castellino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6701538     DOI： 10.1055/s-2007-1004404

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  13 in total

1.  A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator.

Authors:  G L Reed; A K Houng; L Liu; B Parhami-Seren; L H Matsueda; S Wang; L Hedstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Identification of an endothelial cell surface protein that binds plasminogen.

Authors:  A K Dudani; S Hashemi; M T Aye; P R Ganz
Journal:  Mol Cell Biochem       Date:  1991-12-11       Impact factor: 3.396

Review 3.  Streptokinase--the drug of choice for thrombolytic therapy.

Authors:  Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

4.  Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit.

Authors:  M Hermel; M Mahgoub; T Youssef; M I Azrak; H Raza; C Alldredge; M Trese; G A Williams; M Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-20       Impact factor: 3.117

5.  Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.

Authors:  S L Gonias; N L Figler
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

6.  Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.

Authors:  K A Hajjar; R L Nachman
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

7.  A disposable system for rapid purification of autologous plasmin as an adjunct to vitrectomy - performance and safety profile.

Authors:  Martin Hermel; Wendelin Dailey; Michael Trese; Michael K Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-03       Impact factor: 3.117

Review 8.  Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors:  G J del Zoppo; S Wagner; M Tagaya
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 9.  Tranexamic acid: a review of its use in surgery and other indications.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 10.  Thrombolytic therapy in the treatment of stroke.

Authors:  G J del Zoppo
Journal:  Drugs       Date:  1997       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.